FDA Inspection
TOYO Pharmaceutical Co., Ltd.TOYO Pharmaceutical Co., Ltd. – FDA Inspection, Jun 16, 2023
Record Details
This FDA Inspection record concerns TOYO Pharmaceutical Co., Ltd., with an inspection on June 16, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 61a39a53-a2df-4034-88a1-73b0cabcfde6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1208748
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
- 21 CFR 211.25(a)Training , Education , Experience overall
Full citation text and observation details available on the Dashboard.
Other FDA inspections of TOYO Pharmaceutical Co., Ltd.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 12, 2026 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
Other documents for TOYO Pharmaceutical Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.